One-year outcomes in patients undergoing very high-power short-duration ablation for atrial fibrillation

被引:12
作者
Solimene, Francesco [1 ]
Strisciuglio, Teresa [1 ,2 ]
Schillaci, Vincenzo [1 ]
Arestia, Alberto [1 ]
Shopova, Gergana [1 ]
Salito, Armando [1 ]
Bottaro, Giuseppe [1 ]
Marano, Giovanni [1 ]
Coltorti, Fernando [1 ]
Stabile, Giuseppe [1 ,3 ,4 ,5 ]
机构
[1] Clin Montevergine, Mercogliano, AV, Italy
[2] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, NA, Italy
[3] Mediterranea Cardioctr, Naples, NA, Italy
[4] Clin San Michele, Maddaloni, CE, Italy
[5] Anthea Hosp, Bari, BA, Italy
关键词
Atrial fibrillation; Pulmonary vein isolation; Very high-power short-duration; Catheter ablation; Radiofrequency ablation; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION;
D O I
10.1007/s10840-023-01520-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The very high-power short-duration (vHPSD) temperature-controlled ablation (vHPSD) improves the efficiency of pulmonary vein isolation (PVI) procedures.We evaluated the procedural and 12-months outcomes in atrial fibrillation (AF) patients undergoing PVI by means of vHPSD ablation. In patients with AF or atrial tachyarrythmia (AT) recurrence undergoing a redo procedure the durability of the PVI was investigated. Methods Consecutive paroxysmal/persistent AF patients undergoing PVI with the vHPSD ablation strategy (90 W, for 4 s) were enrolled. The rate of PVI, first-pass isolation, acute reconnection, and procedural complications were evaluated. Follow-up examinations and EKG were scheduled at 3,6, and 12 months. In case of AF/AT recurrence, patients underwent a redo procedure. Results Overall, 163 AF patients (29 persistent and 134 paroxysmal) were enrolled. The PVI was reached in 100% of patients (88% at the first pass). The rate of acute reconnection was 2%. The radiofrequency, fluoroscopy and procedural times were respectively 5.5 +/- 1 min, 9 +/- 1 min and 75 +/- 20 min. No death, tamponade nor steam pops occurred; however, 5 patients had vascular complications. The 12-months freedom from AF/AT recurrence was 86% in both paroxysmal and persistent patients. Overall, 9 patients underwent a redo procedure, and in 4 all veins were still isolated, whereas in 5 pulmonary vein reconnections were found. The PVI durability was 78%. No overt clinical complications were observed in the follow-up. Conclusions The vHPSD ablation represents an effective and safe ablation strategy to achieve PVI. The 12-months follow-up showed high freedom from AF/AT recurrence and a good safety profile.
引用
收藏
页码:1911 / 1917
页数:7
相关论文
共 15 条
[1]   High-power and short-duration ablation for pulmonary vein isolation: Safety, efficacy, and long-term durability [J].
Barkagan, Michael ;
Contreras-Valdes, Fernando M. ;
Leshem, Eran ;
Buxton, Alfred E. ;
Nakagawa, Hiroshi ;
Anter, Elad .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (09) :1287-1296
[2]   Catheter ablation of atrial fibrillation using ablation index-guided high-power technique: Frankfurt AI high-power 15-month follow-up [J].
Chen, Shaojie ;
Schmidt, Boris ;
Bordignon, Stefano ;
Tohoku, Shota ;
Urban, Verena C. ;
Schulte-Hahn, Britta ;
Chun, K. R. Julian .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (03) :616-624
[3]   Pulmonary Vein Reconnection No Longer Occurs in the Majority of Patients After a Single Pulmonary Vein Isolation Procedure [J].
De Pooter, Jan ;
Strisciuglio, Teresa ;
El Haddad, Milad ;
Wolf, Michael ;
Phlips, Thomas ;
Vandekerckhove, Yves ;
Tavernier, Rene ;
Knecht, Sebastien ;
Duytschaever, Mattias .
JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (03) :295-305
[4]   Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial [J].
Duytschaever, Mattias ;
Vijgen, Johan ;
De Potter, Tom ;
Scherr, Daniel ;
Van Herendael, Hugo ;
Knecht, Sebastien ;
Kobza, Richard ;
Berte, Benjamin ;
Sandgaard, Niels ;
Albenque, Jean-Paul ;
Szeplaki, Gabor ;
Stevenhagen, Yorick Jeroen ;
Taghji, Philippe ;
Wright, Matthew ;
Macours, Nathalie ;
Gupta, Dhiraj .
EUROPACE, 2020, 22 (11) :1645-1652
[5]   Radiofrequency ablation: technological trends, challenges, and opportunities [J].
Habibi, Mohammadali ;
Berger, Ronald D. ;
Calkins, Hugh .
EUROPACE, 2021, 23 (04) :511-519
[6]   Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury [J].
Halbfass, Philipp ;
Wielandts, Jean-Yves ;
Knecht, Sebastien ;
de Waroux, Jean-Benoit Le Polain ;
Tavernier, Rene ;
De Wilde, Vincent ;
Sonne, Kai ;
Nentwich, Karin ;
Ene, Elena ;
Berkovitz, Artur ;
Mueller, Julian ;
Lehmkuhl, Lukas ;
Reichart, Amelie ;
Lusebrink, Ulrich ;
Duytschaever, Mattias ;
Deneke, Thomas .
EUROPACE, 2022, 24 (03) :400-405
[7]   High-Power and Short-Duration Ablation for Pulmonary Vein Isolation Biophysical Characterization [J].
Leshem, Eran ;
Zilberman, Israel ;
Tschabrunn, Cory M. ;
Barkagan, Michael ;
Contreras-Valdes, Fernando M. ;
Govari, Assaf ;
Anter, Elad .
JACC-CLINICAL ELECTROPHYSIOLOGY, 2018, 4 (04) :467-479
[8]   Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience [J].
Mueller, Julian ;
Halbfass, Philipp ;
Sonne, Kai ;
Nentwich, Karin ;
Ene, Elena ;
Berkovitz, Artur ;
Lehmkuhl, Lukas ;
Barth, Sebastian ;
Simu, Gelu R. ;
Waechter, Christian ;
Behnes, Michael ;
Deneke, Thomas .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (05) :920-927
[9]   Comparison of In Vivo Tissue Temperature Profile and Lesion Geometry for Radiofrequency Ablation With High Power-Short Duration and Moderate Power-Moderate Duration: Effects of Thermal Latency and Contact Force on Lesion Formation [J].
Nakagawa, Hiroshi ;
Ikeda, Atsushi ;
Sharma, Tushar ;
Govari, Assaf ;
Ashton, John ;
Maffre, Jennifer ;
Lifshitz, Alexander ;
Fuimaono, Kristine ;
Yokoyama, Katsuaki ;
Wittkampf, Fred H. M. ;
Jackman, Warren M. .
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (07) :605-617
[10]   Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions The QDOT-FAST Trial [J].
Reddy, Vivek Y. ;
Grimaldi, Massimo ;
De Potter, Tom ;
Vijgen, Johan M. ;
Bulava, Alan ;
Duytschaever, Mattias Francis ;
Martinek, Martin ;
Natale, Andrea ;
Knecht, Sebastien ;
Neuzil, Petr ;
Puererfellner, Helmut .
JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (07) :778-786